Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Interest Expenses (2016 - 2025)

Apyx Medical (APYX) has disclosed Interest Expenses for 11 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest Expenses fell 14.88% year-over-year to $1.4 million, compared with a TTM value of $5.6 million through Dec 2025, down 5.38%, and an annual FY2025 reading of $5.6 million, down 5.38% over the prior year.
  • Interest Expenses was $1.4 million for Q4 2025 at Apyx Medical, roughly flat from $1.4 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $1.7 million in Q4 2024 and bottomed at $1000.0 in Q4 2021.
  • Average Interest Expenses over 5 years is $699950.0, with a median of $564000.0 recorded in 2023.
  • The sharpest move saw Interest Expenses tumbled 88.0% in 2021, then soared 58400.0% in 2023.
  • Year by year, Interest Expenses stood at $1000.0 in 2021, then skyrocketed by 200.0% to $3000.0 in 2022, then surged by 37100.0% to $1.1 million in 2023, then soared by 48.12% to $1.7 million in 2024, then decreased by 14.88% to $1.4 million in 2025.
  • Business Quant data shows Interest Expenses for APYX at $1.4 million in Q4 2025, $1.4 million in Q3 2025, and $1.4 million in Q2 2025.